Preimplantation Genetic Testing for Aneuploidies PGT-A

Preimplantation Genetic Testing for Aneuploidies (PGT-A) is a powerful tool used in assisted reproductive technology (ART) to screen embryos for chromosomal abnormalities. This an innovative technique that allows prospective parents to select embryos with the highest chance of successful implantation and healthy development. This technique increases the likelihood of a successful pregnancy and the birth of a healthy baby.

Preimplantation Genetic Testing for Aneuploidies PGT-A

What is PGT-A?

PGT-A, also known as aneuploidy screening, is a specialized genetic test performed on embryos created through in vitro fertilization (IVF). It aims to identify embryos that have the correct number of chromosomes, specifically screening for aneuploidies, which are abnormalities in the number of chromosomes present in an embryo. Aneuploidies can lead to failed implantation, miscarriages, or the birth of a child with genetic disorders.

How does PGT-A work?

PGT-A involves the biopsy of one or a few cells from an embryo at the blastocyst stage, typically around day five or six after fertilization. The biopsied cells are then analyzed using advanced genetic screening techniques, such as next-generation sequencing (NGS) or array comparative genomic hybridization (aCGH). These techniques provide a detailed analysis of the embryo’s chromosomal makeup, allowing the identification of aneuploidies.

The Benefits of PGT-A

It has multiple benefits that include:

  1. Improved Pregnancy Rates: PGT-A helps identify embryos with the correct number of chromosomes, increasing the chances of successful implantation and pregnancy.
  2. Reduced Miscarriage Risk: Aneuploid embryos have a higher risk of miscarriage. PGT-A allows the selection of chromosomally normal embryos, reducing the likelihood of miscarriages.
  3. Increased IVF Success: PGT-A enables the selection of the healthiest embryos, leading to higher success rates in IVF procedures.
  4. Decreased Genetic Disorder Risk: By identifying embryos with aneuploidies, PGT-A helps prevent the transfer of embryos with genetic disorders, reducing the risk of having a child with a genetic condition. 
  5. Peace of Mind: PGT-A provides prospective parents with valuable genetic information about their embryos, allowing them to make informed decisions and reducing anxiety during the pregnancy journey.

PGT-A Process

The Preimplantation Genetic Testing for Aneuploidies (PGT-A) process involves several steps:

Step 1: Ovarian Stimulation and Egg Retrieval
The woman undergoing PGT-A treatment will undergo ovarian stimulation, which involves the administration of fertility medications to stimulate the ovaries to produce multiple eggs. Once the eggs reach maturity, they are retrieved through a minimally invasive procedure called transvaginal ultrasound aspiration.

Step 2: In Vitro Fertilization (IVF)
The retrieved eggs are then fertilized with sperm in a laboratory through the process of in vitro fertilization (IVF). The resulting embryos are cultured and monitored for several days.

Step 3: Embryo Biopsy
At the blastocyst stage, when the embryo consists of about 100-150 cells, a small number of cells are carefully removed for biopsy. This process is performed by a skilled embryologist using specialized techniques that minimize the impact on embryo development.

Step 4: Genetic Analysis
The biopsied cells are subjected to genetic analysis using advanced techniques like next-generation sequencing or aCGH. These methods provide detailed information about the chromosomal makeup of the embryo, including the identification of aneuploidies.

Step 5: Embryo Selection and Transfer
Based on the genetic analysis results, the most chromosomally normal embryos are selected for transfer into the uterus. The number of embryos transferred is typically determined based on factors such as the woman’s age and previous IVF outcomes, aiming to maximize the chances of a successful pregnancy while minimizing the risk of multiple pregnancies.

Step 6: Cryopreservation of Remaining Embryos
Any remaining embryos that are not transferred can be cryopreserved for future use, offering the opportunity for additional pregnancy attempts without the need for further ovarian stimulation and egg retrieval.


Preimplantation Genetic Testing for Aneuploidies (PGT-A) offers hope to individuals and couples struggling with infertility or genetic concerns. By enabling the selection of chromosomally normal embryos, PGT-A increases the chances of successful pregnancies and healthy babies. This cutting-edge technology, combined with in vitro fertilization (IVF), has revolutionized the field of reproductive medicine and provided new opportunities for building families.

Though PGT-A comes with its set of limitations and considerations, it stands as a valuable tool for individuals aiming to optimize their prospects of successful pregnancies while minimizing the potential risk of genetic disorders. It is imperative to engage in thorough consultations with a fertility specialist to gain a comprehensive understanding of the benefits, risks, and ethical considerations associated with PGT-A. This process helps individuals determine whether PGT-A aligns with their unique circumstances and fertility goals.


PGT-A is recommended for couples who have experienced recurrent miscarriages, failed IVF cycles, advanced maternal age, or a known genetic condition that could be inherited by their offspring.
While PGT-A increases the likelihood of selecting chromosomally normal embryos, it does not guarantee a healthy baby. Other factors, such as the quality of the embryo and the mother's overall health, can still affect the outcome.
The biopsy procedure involved in PGT-A is considered safe for embryos when performed by experienced embryologists. The risk of damage to the embryo is minimal, and studies have shown that PGT-A does not affect embryo development or future health.
PGT-A itself does not pose significant risks. However, the IVF process carries certain risks, such as ovarian hyperstimulation syndrome (OHSS) and multiple pregnancies. These risks should be discussed with a fertility specialist before undergoing PGT-A.
The success rate of PGT-A varies depending on several factors, including the woman's age, the quality of the embryos, and the underlying fertility issues. On average, PGT-A can increase the success rate of IVF by 10-15%.

Top Doctors for this Procedure

Doctors and Surgeons on our panel are renowned and highly experienced.

Need assistance for choosing the best doctor for your medical problem?

    Top Hospital's